PRNewsWire
05 Oct 2026, 07:28 UTC · 1h ago
ARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY
Impact · against what's priced in
The news is a negative catalyst for SPRY due to new allegations of commercialization delays for neffy. For BABA and UWMC, the notice is noise as their prices already incorporate the risk of ongoing securities class action lawsuits.
- BABA+0.00
Already priced in
- The price assumes
The ongoing securities class action lawsuit alleging undisclosed affiliation with the Chinese Ministry of Industry and Information Technology.





